Suppr超能文献

[用二价多糖(A加C)疫苗免疫后针对C群脑膜炎奈瑟菌菌株的杀菌抗体研究]

[Study on the bactericidal antibody against Neisseria meningitidis serogroup C strains after immunization with a divalent polysaccharide (A plus C) vaccine].

作者信息

Xu Li, Luo Long-Ze, Zhu Bing-Qing, He Li, Gao Yuan, Shao Zhu-Jun

机构信息

State Key Laboratory for Infectious Disease Control and Prevention, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

出版信息

Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Jun;30(6):619-21.

Abstract

OBJECTIVE

To optimize the serum bactericidal assay (SBA), detect and analyze the bactericidal antibody level against Neisseria meningitidis serogroup C strains after divalent polysaccharide (A plus C) vaccine immunization.

METHODS

Two Neisseria meningitidis serogroup C strains, vaccine candidate strain (C11) and epidemic strain (053442), were selected as targets. The national Neisseria meningitidis standardized serum was used as reference serum. Pel-Freez infant rabbit complements was available. The optimized SBA method was used to detect bactericidal antibody against strain C11 and 053442 for 122 pairs of sera before and after immunization with a divalent polysaccharide (A and C) vaccine.

RESULTS

The strain C11 and 053442 both could be used as targeted strain for SBA. The optimized concentration of targeted strain was achieved when a whole-cell suspension of 0.35 A at 600 nm was diluted 4 x 10(4) times. Before immunization, SBA geometric mean titers (GMT) of 122 sera against strain C11 and 053442 were 1:1.75 and 1:2.63 respectively, and the protective rates were 9.8% and 17.2% respectively. After immunization, the GMTs and the protective rates of 122 sera both rose significantly (P<0.01), the GMTs against strain C11 and 053442 were 1:483.73 and 1:412.57 respectively. The protective rates against strain C11 and 053442 were 100% and 95.9% respectively.

CONCLUSION

Immunization with a divalent polysaccharide (A and C) vaccine could elevate remarkably the population SBA titer against Neisseria meningitidis serogroup C strains of different subtypes, but the surveillance of vaccine effect against different targeted strains remains necessary.

摘要

目的

优化血清杀菌试验(SBA),检测并分析二价多糖(A加C)疫苗免疫后针对C群脑膜炎奈瑟菌菌株的杀菌抗体水平。

方法

选择两株C群脑膜炎奈瑟菌菌株,候选疫苗株(C11)和流行株(053442)作为靶标。使用国家脑膜炎奈瑟菌标准化血清作为参考血清。采用Pel-Freez幼兔补体。运用优化后的SBA方法检测122对血清在二价多糖(A和C)疫苗免疫前后针对C11株和053442株的杀菌抗体。

结果

C11株和053442株均可作为SBA的靶标菌株。当600nm波长下吸光度为0.35的全菌悬液稀释4×10⁴倍时可达到靶标菌株的优化浓度。免疫前,122份血清针对C11株和053442株的SBA几何平均滴度(GMT)分别为1:1.75和1:2.63,保护率分别为9.8%和17.2%。免疫后,122份血清的GMT和保护率均显著升高(P<0.01),针对C11株和053442株的GMT分别为1:483.73和1:412.57。针对C11株和053442株的保护率分别为100%和95.9%。

结论

二价多糖(A和C)疫苗免疫可显著提高人群针对不同亚型C群脑膜炎奈瑟菌菌株的SBA滴度,但仍有必要监测疫苗针对不同靶标菌株的效果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验